跳至主要内容
临床试验/NCT05069883
NCT05069883已完成不适用

Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy

Services Hospital, Lahore1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
180
试验地点
1
主要终点
Recurrence of Urethral Stricture

研究概览

简要总结

It was a randomized controlled trial conducted at department of Urology, Armed Forces Institute of Urology, Rawalpindi from 1st January, 2018 July 2019 to 31st March 2021 to determine the role of oral steroids after Direct Vision Internal Urethrotomy to reduce the recurrence rate of urethral strictures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients with urethral stricture with restricted urine flow of < 15 ml/min on uroflowmetry

排除标准

  • Patients presenting with post-anastomotic urethroplasty strictures (assessed on history and medical record),
  • Patients with post-TURP strictures
  • Patients with neurogenic bladder
  • Patients with prior history of steroid use
  • Patients with extravasation during optical internal urethrotomy

研究组 & 干预措施

Oral Steroid

Experimental

In this group oral steroids were given after Direct vision internal urethrotomy

干预措施: Steroid Drug (Drug)

No Oral Steroids

Placebo Comparator

In this group no oral steroids were given after Direct vision internal urethrotomy

干预措施: No steroid (Drug)

结局指标

主要结局

Recurrence of Urethral Stricture

时间窗: 6 months post-operatively

Number of patients presenting with recurrence of urethral stricture after direct vision internal urethrotomy

次要结局

未报告次要终点

研究者

发起方
Services Hospital, Lahore
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. SamiUllah

Principal Investigator

Services Hospital, Lahore

研究点 (1)

Loading locations...

相似试验